Send to a Friend Font Size: Increase Decrease

SCLX and SRNEQ Related Headlines

Jul 7, 2026 06:00AM Semnur signs $100M binding term sheet with Kazakhstan investor
Jul 7, 2026 06:00AM Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strat

SCLX and SRNEQ Related Press Releases

Jul 7, 2026 06:00AM Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strat

SCLX and SRNEQ Related SEC Filings